Lumos Pharma | NLNK - Aktuelle Verpflichtungen



Aktuelle Verpflichtungen Veränderung Datum
Agenus USD 231.82M 17.42M 2026-06
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Capricor Therapeutics USD 32.96M 676K 2026-06
Celldex Therapeutics USD 61.32M 9.85M 2026-06
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 47.74B 11.11B 2026-06
Grifols EUR 2.37B 156.97M 2025-12
Incyte USD 1.31B 177.55M 2026-06
Intrexon USD 23.02M 38K 2024-06
Merck USD 27.73B 786M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Pfizer USD 32.65B 1.7B 2026-06
Prothena USD 11.66M 20.86M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06